Brent Binkowski Biography and Net Worth

COO of CVRx

Brent Binkowski has served as the Company’s Chief Operating Officer since August 2025, bringing over 20 years of leadership in the medical device industry, specializing in implantable devices for interventional cardiology, radiology, and urology. Previously, Mr. Binkowski served as Vice President of Operations – Interventional Urology at Coloplast, Vice President of US Manufacturing at Teleflex Medical, and Senior Vice President of Operations at Vascular Solutions. Prior to that, he was Vice President of Operations at CeloNova BioSciences and Senior Director of Operations at Endo Pharmaceuticals (American Medical Systems). Mr. Binkowski’s career began with Graco Inc. and Independent Packing Services Inc. as a packaging engineer and sales engineer/project manager, followed by leadership positions of increasing responsibility at American Medical Systems. He holds an M.B.A. from the University of Minnesota’s Carlson School of Management and a B.S. in Industrial Technology – Packaging Engineering from the University of Wisconsin-Stout.

What is Brent Binkowski's net worth?: The estimated net worth of Brent Binkowski is at least $172.09 thousand as of August 13th, 2026. Mr. Binkowski owns 56,514 shares of CVRx stock worth more than $172,085 as of September 17th. This net worth estimate does not reflect any other investments that Mr. Binkowski may own. Learn More about Brent Binkowski's net worth.
How do I contact Brent Binkowski?: The corporate mailing address for Mr. Binkowski and other CVRx executives is 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, 55445. CVRx can also be reached via phone at (763) 416-2850 and via email at [email protected]. Learn More on Brent Binkowski's contact information.
Has Brent Binkowski been buying or selling shares of CVRx?: Within the last three months, Brent Binkowski has bought $76,308.93 in CVRx stock and sold $3,337.95 in CVRx stock. Most recently, on Thursday, August 13th, Brent Binkowski bought 26,223 shares of CVRx stock. The stock was acquired at an average cost of $2.91 per share, with a total value of $76,308.93. Following the completion of the transaction, the chief operating officer now directly owns 56,514 shares of the company's stock, valued at $164,455.74. Learn More on Brent Binkowski's trading history.
Who are CVRx's active insiders?: CVRx's insider roster includes Brent Binkowski (COO), Mudit Jain (Director), and Kirk Nielsen (Director). Learn More on CVRx's active insiders.
Are insiders buying or selling shares of CVRx?: During the last twelve months, CVRx insiders bought shares 3 times. They purchased a total of 73,623 shares worth more than $376,740.93. During the last twelve months, insiders at the sold shares 7 times. They sold a total of 58,803 shares worth more than $586,749.47. The most recent insider tranaction occured on August, 13th when COO Brent Binkowski bought 26,223 shares worth more than $76,308.93. Insiders at CVRx own 16.6% of the company. Learn More about insider trades at CVRx.
Information on this page was last updated on 8/13/2026.

Brent Binkowski Insider Trading History at CVRx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/13/2026	Buy	26,223	$2.91	$76,308.93	56,514
8/12/2026	Sell	1,309	$2.55	$3,337.95	30,291

Brent Binkowski Buying and Selling Activity at CVRx

CVRx Company Overview

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Today's Range

Now: $2.99

$2.98

$3.08

50 Day Range

MA: $3.87

$2.37

$5.94

2 Week Range

Now: $2.99

$2.20

$11.30

Volume

196,124 shs

Average Volume

498,721 shs

Market Capitalization

$79.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76